Literature DB >> 31297604

[What is new on gout? : Report from ACR 2018].

J Braun1,2, U Kiltz3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31297604     DOI: 10.1007/s00393-019-0667-y

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  10 in total

1.  Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.

Authors:  Hugh de Lautour; William J Taylor; Ade Adebajo; Rieke Alten; Ruben Burgos-Vargas; Peter Chapman; Marco A Cimmino; Geraldo da Rocha Castelar Pinheiro; Ric Day; Leslie R Harrold; Philip Helliwell; Matthijs Janssen; Gail Kerr; Arthur Kavanaugh; Dinesh Khanna; Puja P Khanna; Chingtsai Lin; Worawit Louthrenoo; Geraldine McCarthy; Janitzia Vazquez-Mellado; Ted R Mikuls; Tuhina Neogi; Alexis Ogdie; Fernando Perez-Ruiz; Naomi Schlesinger; H Ralph Schumacher; Carlo A Scirè; Jasvinder A Singh; Francisca Sivera; Ole Slot; Lisa K Stamp; Anne-Kathrin Tausche; Robert Terkeltaub; Till Uhlig; Mart van de Laar; Douglas White; Hisashi Yamanaka; Xuejun Zeng; Nicola Dalbeth
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-05       Impact factor: 4.794

2.  Gout and chronic pain in older adults: a Medicare claims study.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Clin Rheumatol       Date:  2019-03-29       Impact factor: 2.980

3.  Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout.

Authors:  William B White; Kenneth G Saag; Michael A Becker; Jeffrey S Borer; Philip B Gorelick; Andrew Whelton; Barbara Hunt; Majin Castillo; Lhanoo Gunawardhana
Journal:  N Engl J Med       Date:  2018-03-12       Impact factor: 91.245

4.  Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.

Authors:  Yanyan Zhu; Bhavik J Pandya; Hyon K Choi
Journal:  Arthritis Rheum       Date:  2011-10

5.  Treat-to-target (T2T) recommendations for gout.

Authors:  U Kiltz; J Smolen; T Bardin; A Cohen Solal; N Dalbeth; M Doherty; B Engel; C Flader; J Kay; M Matsuoka; F Perez-Ruiz; G da Rocha Castelar-Pinheiro; K Saag; A So; J Vazquez Mellado; M Weisman; T H Westhoff; H Yamanaka; J Braun
Journal:  Ann Rheum Dis       Date:  2016-09-22       Impact factor: 19.103

6.  Frequency, distribution and immunologic nature of infusion reactions in subjects receiving pegloticase for chronic refractory gout.

Authors:  Leonard H Calabrese; Arthur Kavanaugh; Anthony E Yeo; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2017-08-17       Impact factor: 5.156

7.  Gout, flares, and allopurinol use: a population-based study.

Authors:  Charlotte Proudman; Susan E Lester; David A Gonzalez-Chica; Tiffany K Gill; Nicola Dalbeth; Catherine L Hill
Journal:  Arthritis Res Ther       Date:  2019-05-31       Impact factor: 5.156

8.  Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.

Authors:  Nicola Dalbeth; Christopher Frampton; Maple Fung; Scott Baumgartner; Savvas Nicolaou; Hyon K Choi
Journal:  Arthritis Res Ther       Date:  2019-06-21       Impact factor: 5.156

Review 9.  2016 updated EULAR evidence-based recommendations for the management of gout.

Authors:  P Richette; M Doherty; E Pascual; V Barskova; F Becce; J Castañeda-Sanabria; M Coyfish; S Guillo; T L Jansen; H Janssens; F Lioté; C Mallen; G Nuki; F Perez-Ruiz; J Pimentao; L Punzi; T Pywell; A So; A K Tausche; T Uhlig; J Zavada; W Zhang; F Tubach; T Bardin
Journal:  Ann Rheum Dis       Date:  2016-07-25       Impact factor: 19.103

10.  Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Christian Mallen; Weiya Zhang; Michael Doherty
Journal:  Ann Rheum Dis       Date:  2014-01-15       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.